All AbMole products are for research use only, cannot be used for human consumption.
CID1231538 is a potent GPR35 antagonist, with IC50 of 0.55 μM. CID1231538 is a benzothiazole analogue. GPR35 is a G protein-coupled receptor. GPR35 has gained special consideration as a result of its association with many diseases including type-2 diabetes, nociceptive pain, inflammation, mild mental retardation syndrome, metabolic disorders, and gastric cancer.
Molecular Weight | 524.05 |
Formula | C26H22ClN3O3S2 |
CAS Number | 354126-20-8 |
Solubility (25°C) | DMSO 50 mg/mL |
Storage | 4°C, protect from light |
Related GPR/FFAR Products |
---|
GPR84 antagonist 8
GPR84 antagonist 8 is a selective GPR84 antagonist. |
ML191
ML-191 is an antagonist of GPR55. |
CID1172084
CID1172084 is a selective GPR55 agonist (EC50=0.16 μM). |
ML 145
ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM. |
PSN 375963 hydrochloride
PSN 375963 hydrochloride is a potent GPR119 agonist, with EC50s of 8.4 and 7.9 μM for human and mouse GPR119, respectively. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.